Current Psychiatry Reports

, Volume 7, Issue 2, pp 91–97

Treatment of mania in children and adolescents

  • Roomana Sheikh
  • Joon Kang
  • Ronald Weller
  • Elizabeth B. Weller
Article
  • 57 Downloads

Abstract

Bipolar disorder (BPD) is a severe and complex illness that seriously disrupts the lives of those afflicted. Increased rates of suicide attempts and completions, poorer academic performances, disturbed interpersonal relationships, increased rates of substance abuse, legal difficulties, and multiple hospitalizations all have been associated with BPD. At least 1% of children and adolescents have this disorder. This commentary is designed to review and summarize the recent literature on the treatment of manic and/or hypomanic phases of BPD in children and adolescents,

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Akiskal HS, Downs J, Jordan P, et al.: Affective disorders in referred children and younger siblings of manic-depressives. Mode of onset and prospective course. Arch Gen Psychiatry 1985, 42:996–1003.PubMedGoogle Scholar
  2. 2.
    Kashani JH, Beck NC, Hoeper EW, et al.: Psychiatric disorders in a community sample of adolescents. Am J Psychiatry, 1987, 144:584–589.PubMedGoogle Scholar
  3. 3.
    Lewinsohn PM, Klein DN, Seeley JR: Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 1995, 4:454–463.CrossRefGoogle Scholar
  4. 4.
    Strober M, Schmidt-Lackner S, Freeman R, et al.: Recovery and relapse in adolescents with bipolar affective illness: a fiveyear naturalistic, prospective follow-up. J Am Acad Child Adolesc Psychiatry 1995, 34:724–231.PubMedCrossRefGoogle Scholar
  5. 5.
    Geller B, Zimerman B, Williams M, et al.: DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. J Child Adolesc Psychopharmacology 2002, 12:11–25.CrossRefGoogle Scholar
  6. 6.
    Geller B, Zimerman B, Williams M, et al.: Phenomenology of prepubertal and early adolescent bipolar disorder: examples of elated mood, grandiose behaviors, decreased need for sleep, racing thoughts and hypersexuality. Journal Child Adolesc Psychopharmacology 2002, 12:3–9.CrossRefGoogle Scholar
  7. 7.
    Findling RL, Gracious BL, McNamara NK, et al.: Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder. Bipolar Disord 2001, 3:202–210.PubMedGoogle Scholar
  8. 8.
    Wozniak J, Biederman J, Kiely K, et al.: Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry 1995, 34:867–876.PubMedCrossRefGoogle Scholar
  9. 9.
    Anonymous: Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. AACAP. J Am Acad Child Adolesc Psychiatry 1998, 37:63S–83S.Google Scholar
  10. 10.
    McElroy SL, Keck Jr PE: Pharmacologic agents for the treatment of acute bipolar mania. Biol Psychiatry 2000, 48:615–624.PubMedCrossRefGoogle Scholar
  11. 11.
    Brambilla P, Barale F, Soares JC: Atypical antipsychotics and mood stabilization in bipolar disorder. Psychopharmacology 2003, 166:315–332.PubMedGoogle Scholar
  12. 12.
    Weller EB, Danielyan AK, Weller RA: Somatic treatment of bipolar disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am 2002, 11:595–617. This article reviews evidence-based pharmacotherapy options for bipolar disorder in children and adolescents.PubMedCrossRefGoogle Scholar
  13. 13.
    Solomon DA, Ryan CE, Keitner GI, et al.: A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder. J Clin Psychiatry 1997, 58:95–99.PubMedGoogle Scholar
  14. 14.
    Tohen M, Chengappa KNR, Suppes T: Efficacy of olanzapine in combination with valproate or lithium for relapse prevention of bipolar disorder: an 18-month study. Presented at the American Psychiatric Association Annual Meeting. Philadelphia, PA; May 18–23, 2002.Google Scholar
  15. 15.
    Weller EB, Danielyan AK, Weller RA: Somatic treatment of bipolar disorder in children and adolescents. N Am J Child Adolesc Psychiatr Clin 2002, 11:595–617.CrossRefGoogle Scholar
  16. 16.
    Strober M, Morrell W, Burroughs J, et al.: A family study of bipolar I disorder in adolescence: early onset of symptoms linked to increased familial loading and lithium resistance. J Affect Disord 1988, 15:255–268.PubMedCrossRefGoogle Scholar
  17. 17.
    Kafantaris V, Coletti DJ, Dicker R, et al.: Lithium treatment of acute mania in adolescents: a large open trial. J AmAcad Child Adolesc Psychiatry 2003, 42:1038–1045. The authors study the efficacy of lithium in treating acute mania in a large group of adolescents. Responders to lithium then were randomized into either placebo or lithium for a 2-week double-blind, controlled phase.CrossRefGoogle Scholar
  18. 18.
    Kafantaris V, Coletti DJ, Dicker R, et al.: Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study. J Am Acad Child Adolesc Psychiatry 2004, 43:984–993. The authors present the results of a double-blind placebo controlled discontinuation study of lithium in treating BPD.PubMedCrossRefGoogle Scholar
  19. 19.
    Geller B, Cooper TB, Sun K, et al.: Double-blind and placebocontrolled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998, 37:171–178.PubMedCrossRefGoogle Scholar
  20. 20.
    DeLong GR, Aldershof AL: Long-term experience with lithium treatment in childhood: correlation with clinical diagnosis. J Am Acad Child Adolesc Psychiatry 1987, 26:389–394.PubMedCrossRefGoogle Scholar
  21. 21.
    DeLong GR, Nieman GW: Lithium-induced behavior changes in children with symptoms suggesting manic-depressive illness. Psychopharmacol Bull 1983, 19:258–265.PubMedGoogle Scholar
  22. 22.
    Varanka TM, Weller RA, Weller EB, et al.: Lithium treatment of manic episodes with psychotic features in prepubertal children. Am J Psychiatry 1988, 145:1557–1559.PubMedGoogle Scholar
  23. 23.
    Weller EB, Weller RA, Fristad MA: Lithium dosage guide for prepubertal children: a preliminary report. J Am Acad Child Adolesc Psychiatry 1986, 25:92–95.CrossRefGoogle Scholar
  24. 24.
    McKnew DH, Cytryn L, Buchsbaum MS, et al.: Lithium in children of lithium-responding parents. Psychiatry Res 1981, 4:171–180.PubMedCrossRefGoogle Scholar
  25. 25.
    Strober M, Morrell W, Lampert C, et al.: Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study. Am J Psychiatry 1990, 147:457–461.PubMedGoogle Scholar
  26. 26.
    Hagino OR, Weller EB, Weller RA, et al.: Untoward effects of lithium treatment in children aged four through six years. J Am Acad Child Adolesc Psychiatry 1995, 34:1584–1590.PubMedCrossRefGoogle Scholar
  27. 27.
    Campbell M, Silva RR, Kafantaris V, et al.: Predictors of side effects associated with lithium administration in children. Psychopharmacol Bull 1991, 27:373–380.PubMedGoogle Scholar
  28. 28.
    Rosenberg DR, Holttum J, Gershon S: Textbook of Pharmacotherapy for Child and Adolescent Psychiatric Disorders. New York: Brunner/Mazel; 1994.Google Scholar
  29. 29.
    Bowden CL: Predictors of response to divalproex and lithium. J Clin Psychiatry 1995, 56(Suppl 3):25–30.PubMedGoogle Scholar
  30. 30.
    Calabrese JR, Fatemi SH, Kujawa M, et al.: Predictors of response to mood stabilizers. J Clinical Psychopharmacol 1996, 16(Suppl):24S-31S.CrossRefGoogle Scholar
  31. 31.
    West SA, Keck PEJ, McElroy SL, et al.: Open trial of valproate in the treatment of adolescent mania. J Child Adolesc Psychopharmacol 1994, 4:263–67.Google Scholar
  32. 32.
    Papatheodorou G, Kutcher SP, Katic M, et al.: The efficacy and safety of diavalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinical trial. J Clin Psychopharmacol 1995, 15:110–116.PubMedCrossRefGoogle Scholar
  33. 33.
    West SA, McElroy SL: Oral loading doses in the valproate treatment of adolescents with mixed bipolar disorder. J Child Adolesc Psychopharmacol 1995, 5:225–231.Google Scholar
  34. 34.
    Whittier MC, West SA, Galli VB, et al.: Valproic acid for dysphoric mania in a mentally retarded adolescent. J Clin Psychiatry 1995, 56:590–591.PubMedGoogle Scholar
  35. 35.
    Wagner KD, Weller EB, Carlson GA, et al.: An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2002, 41:1224–1230.PubMedCrossRefGoogle Scholar
  36. 36.
    Isojarvi JI, Laatikainen TJ, Pakarinen AJ, et al.: Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993, 329:1383–1388.PubMedCrossRefGoogle Scholar
  37. 37.
    Weller EB, Danielyan AK, Weller RA: Somatic treatment of bipolar disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am 2002, 11:595–617.PubMedCrossRefGoogle Scholar
  38. 38.
    Woolston JL: Case study: carbamazepine treatment of juvenile-onset bipolar disorder. J Am Acad Child Adolesc Psychiatry, 1999, 38:335–338.PubMedCrossRefGoogle Scholar
  39. 39.
    Tuzun U, Zoroglu SS, Savas HA: A 5-year old boy with recurrent mania successfully treated with carbamazepine. Psychiatry Clin Neurosci 2002, 56:589–591.PubMedCrossRefGoogle Scholar
  40. 40.
    Kowatch RA, Suppes T, Carmody TJ, et al.: Effect size of lithium, divalproex sodium, and cabamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000, 39:713–720.PubMedCrossRefGoogle Scholar
  41. 41.
    Cueva JE, Overall JE, Small AM, et al.: Carbamazapine in aggressive children with conduct disorder: a double blind and placebo controlled study. J Am Acad Child Adolesc Psychiatry 1988, 35:480–490.CrossRefGoogle Scholar
  42. 42.
    Worrel JA, Marken PA, Beckman SE, et al.: Atypical antipsychotic agents: a critical review. Am J Health Syst Pharm 2000, 57:238–255.PubMedGoogle Scholar
  43. 43.
    Smith CD, Reynard AM (Eds): Textbook of Pharmacology. Philadelphia: Saunders; 1992:271.Google Scholar
  44. 44.
    Fuchs DC: Clozapine treatment of bipolar disorder in a young adolescent. J Acad Child Adolesc Psychiatry 1994, 33:1299–1302.CrossRefGoogle Scholar
  45. 45.
    Masi G, Milone A: Clozapine treatment in an adolescent with bipolar disorder. Panminerva Med 1998, 40:254–257.PubMedGoogle Scholar
  46. 46.
    Masi G, Mucci M, Millepiedi S: Clozapine in adolescent inpatients with acute mania. J Am Acad Child Adolesc Psychopharmacol 2002, 12:93–99.CrossRefGoogle Scholar
  47. 47.
    Tohen M, Jacobs TG, Grundy SL, et al.: Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry 2000, 57:841–849.PubMedCrossRefGoogle Scholar
  48. 48.
    Frazier JA, Biederman J, Tohen M, et al.: A prospective openlabel treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharamcol 2001, 11:239–250.CrossRefGoogle Scholar
  49. 49.
    Soutullo CA, Sorter MT, Foster KD, et al.: Olanzapine in the treatment of adolescent acute mania: a report of seven cases. J Affect Disord 1999, 53:279–283.PubMedCrossRefGoogle Scholar
  50. 50.
    Del Bello MP, Schwiers ML, Rosenberg HL, et al.: A doubleblind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002, 41:1216–1223.CrossRefGoogle Scholar
  51. 51.
    Patel NC, Sierk P, Dorson PG, et al.: Experience with ziprasidone. J Am Acad Child Adolesc Psychiatry 2002, 41:495.PubMedCrossRefGoogle Scholar
  52. 52.
    Frazier JA, Meyer MC, Biederman J, et al.: Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry 1999, 38:960–965.PubMedCrossRefGoogle Scholar
  53. 53.
    Martin A, Landau J, Leebens P, et al.: Risperidone-associated weight gain in children and adolescents: a retrospective chart review. J Child Adolesc Psychopharmacol 2000, 10:259–268.PubMedGoogle Scholar
  54. 54.
    Szigethy E, Wiznitzer M, Branicky LA, et al.: Risperidoneinduced hepatotoxicity in children and adolescents? J Child Adolesc Psychopharmacol 1999, 9:93–98.PubMedCrossRefGoogle Scholar
  55. 55.
    Findling RL, McNamara NK, Gracious BL, et al.: Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 2003, 42:895–901.PubMedCrossRefGoogle Scholar
  56. 56.
    Kowatch RA, Sethuraman G, Hume JH, et al.: Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol Psychiatry 2003, 53:978–984.PubMedCrossRefGoogle Scholar
  57. 57.
    Kafantaris V: Treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 1995, 34:732–741.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc. 2005

Authors and Affiliations

  • Roomana Sheikh
    • 1
  • Joon Kang
  • Ronald Weller
  • Elizabeth B. Weller
  1. 1.Drexel College of MedicinePhiladelphiaUSA

Personalised recommendations